Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type I diabetes population

Metabolism: Clinical and Experimental

Volumn 48, Issue 4, 1999, Pages 531-534

  Erbey, John R ^b   Robbins, David ^b   Forrest, Kimberly Y Z ^b   Orchard, Trevor J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES CONTROL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POPULATION RESEARCH; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0032965368     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90116-6     Document Type: Article

References (32)

1. National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89:1329-1445, 1994
2. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
3. Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001-1009, 1996
4. Stamler J, Wentworth D, Neaton JD: Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256:2823-2828, 1986
5. Selby JV, Austin MA, Newman B, et al: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 85:381-387, 1993
6. Austin M, King MC, Vranizan K, et al: Low density lipoprotein subclass patterns: A common genetic marker for increased coronary heart disease risk. Arteriosclerosis 8:615a, 1988 (abstr)
7. Crouse JR, Parks JS, Schey HM, et al: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985
8. Campos H, Genest JJ, Blijlevens E, et al: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
9. Coresh J, Kwiterovich PO, Smith HH, et al: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34:1687-1697, 1993
10. Griffin BA, Freeman DJ, Tait GW. et al: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subtractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253, 1994
11. Lamarche B, Tchernof A, Moorjani A, et al: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 95:69-75, 1997
12. Grundy SM: Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95:1-4, 1997
13. Haffner SM, Paidi M, Mykkanen L, et al: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164-1171, 1994
14. Orchard TJ, Dorman JS, Maser RE, et al: Factors associated with the avoidance of severe complications after 25 years of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 13:741-747, 1990
15. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoprotein in normal humans. J Lipid Res 23:1375-1384, 1982
16. Borhani NO, Kass EH, Langford HG, et al. The Hypertension Detection Follow-up Program. Prev Med 5:207-215, 1976
17. Erbey JR, Kuller LH, Becker DJ, et al: The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 21:610-614, 1998
18. Orchard TJ, Dorman JS, Maser RE, et al: Prevalence of complications in IDDM by sex and duration. Diabetes 39:1116-1124, 1990
19. Beck AT. Garbin MG: Psychometric properties of the Beck Depression Inventory, 25 years of evaluation. Clin Psychol Rev 8:77-100, 1988
20. Ellis D, Coonrod BA, Dorman JS, et al: Choice of urine predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 13:321-328, 1989
21. Kuller LH, Orchard TJ: The epidemiology of atherosclerosis in 1987: Unraveling a common source epidemic. Clin Chem 34:B40-B48, 1988
22. Pyorala K. Pedersen TR, Kjekshus J, et al: Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
23. Nigon F, Lesnik P, Rouis M, et al: Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 32:1741-1753, 1991
24. LaBelle M, Krauss RM: Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res 31:1577-1588, 1990
25. Dejagr S, Bruckert E, Chapman MJ: Dense low density lipopro-tein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 34:295-308, 1993
26. Barakat HA, Carpenter JW, McLendon VD, et al: Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: Possible link between hyperinsulinemia and atherosclerosis. Diabetes 39:1527-1533, 1990
27. Finegold KR, Grunfeld C, Doerrler W, et al: subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Arterioscler Thromb 12:1496-1502. 1992
28. Purnell JQ, Marcovina SM, Hoaknson JE, et al: Levels of lipoprotein(a). apolipoprotein B. and lipoprotein cholesterol distribution in IDDM: Results from follow-up in the DCCT. Diabetes 44:1218-1226, 1995
29. The Diabetes Control and Complications Trial (DCCT) Research Group Effect of intensive diabetes management on macrovascular events and risk factors in the DCCT. Am J Cardiol 75:894-903, 1995
30. Haffner SM, Stern MP, Hazuda HP, et al: Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 9:928-933, 1989
31. Wingard DL, Barrett-Connor E: Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic. borderline hyperglycemic, and diabetic adults. Am J Epidemiol 125:948-958, 1987
32. Lloyd CE. Kuller LH, Ellis D, et al: Coronary artery disease in IDDM. gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 16:720-726, 1996